BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 9868832)

  • 1. [Results of field studies using Stellamune mycoplasma vaccine in Luxembourg].
    Schoos J
    Bull Soc Sci Med Grand Duche Luxemb; 1998; 135(1):43-50. PubMed ID: 9868832
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of the Stellamune Mycoplasma vaccine on growth, energy conversion, death, and medication use in fattening pigs on a pig farm chronically infected with Mycoplasma hyopneumoniae].
    Bouwkamp FT; Elbers AR; Hunneman WA; Klaassen CH
    Tijdschr Diergeneeskd; 2000 Jul; 125(14):444-8. PubMed ID: 10948597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aerosol vaccination of pigs against Mycoplasma hyopneumoniae infection.
    Murphy D; Van Alstine WG; Clark LK; Albregts S; Knox K
    Am J Vet Res; 1993 Nov; 54(11):1874-80. PubMed ID: 8291766
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune response against the L-lactate dehydrogenase of Mycoplasma hyopneumoniae in enzootic pneumonia of swine.
    Frey J; Haldimann A; Kobisch M; Nicolet J
    Microb Pathog; 1994 Nov; 17(5):313-22. PubMed ID: 7723658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Experiments to obtain and test vaccines against enzootic pneumonia in swine].
    Stoianov V
    Vet Med Nauki; 1976; 13(9):24-7. PubMed ID: 1025843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction between Mycoplasma hyopneumoniae and swine influenza virus.
    Thacker EL; Thacker BJ; Janke BH
    J Clin Microbiol; 2001 Jul; 39(7):2525-30. PubMed ID: 11427564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Field study with a vaccine against enzootic pneumonia of swine].
    Schatzmann E; Keller H; Grest P; Lorenz D; Burri W
    Schweiz Arch Tierheilkd; 1996; 138(10):483-9. PubMed ID: 9011940
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A meta-analysis comparing the effect of vaccines against Mycoplasma hyopneumoniae on daily weight gain in pigs.
    Jensen CS; Ersbøll AK; Nielsen JP
    Prev Vet Med; 2002 Jul; 54(3):265-78. PubMed ID: 12114013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential use of a recombinant replication-defective adenovirus vector carrying the C-terminal portion of the P97 adhesin protein as a vaccine against Mycoplasma hyopneumoniae in swine.
    Okamba FR; Arella M; Music N; Jia JJ; Gottschalk M; Gagnon CA
    Vaccine; 2010 Jul; 28(30):4802-9. PubMed ID: 20472025
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isolation of Mycoplasma hyopneumoniae from lesions in experimentally infected pigs.
    Etheridge JR; Cottew GS; Lloyd LC
    Aust Vet J; 1979 Aug; 55(8):356-9. PubMed ID: 533486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mycoplasma hyopneumoniae: interaction with other agents in pigs, and evaluation of immunogens.
    Ciprián A; Cruz TA; de la Garza M
    Arch Med Res; 1994; 25(2):235-9. PubMed ID: 7919820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of Mycoplasma hyopneumoniae antibodies in porcine serum by complement-fixation test.
    Blackburn BO; Wright HS; Ellis EM
    Am J Vet Res; 1975 Sep; 36(9):1381-2. PubMed ID: 1163882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of Mycoplasma hyopneumoniae inactivated vaccine in pigs under field conditions.
    Okada M; Sakano T; Senna K; Maruyama T; Murofushi J; Okonogi H; Sato S
    J Vet Med Sci; 1999 Oct; 61(10):1131-5. PubMed ID: 10563291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparison of the use of a vaccine and sequential antibiotic treatment in a herd infected with Mycoplasma hyopneumoniae].
    Le Grand A; Kobisch M
    Vet Res; 1996; 27(3):241-53. PubMed ID: 8767886
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Demonstration of complement-fixation antibody against Mycoplasma hyopneumoniae in the sera of pigs infected with swine enzootic pneumonia.
    Takatori I; Huhn RG; Switzer WP
    Natl Inst Anim Health Q (Tokyo); 1968; 8(4):195-203. PubMed ID: 5753358
    [No Abstract]   [Full Text] [Related]  

  • 16. [Vaccines against respiratory diseases of swine: example Mycoplasma hyopneumoniae].
    Blanchard B; Kobisch M
    Vet Res; 1995; 26(3):213-4. PubMed ID: 7795681
    [No Abstract]   [Full Text] [Related]  

  • 17. Reduction of mycoplasmal lesions and clinical signs by vaccination against Mycoplasma hyorhinis.
    Lee JA; Hwang MA; Han JH; Cho EH; Lee JB; Park SY; Song CS; Choi IS; Lee SW
    Vet Immunol Immunopathol; 2018 Feb; 196():14-17. PubMed ID: 29695319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of enzyme-linked immunosorbent assay (ELISA) and indirect hemagglutination (IHA) in experimental Mycoplasma hyopneumoniae infection of pigs.
    Kobisch M; Nicolet J
    Isr J Med Sci; 1987 Jun; 23(6):644-6. PubMed ID: 3667230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral immunization of swine with attenuated Salmonella typhimurium aroA SL3261 expressing a recombinant antigen of Mycoplasma hyopneumoniae (NrdF) primes the immune system for a NrdF specific secretory IgA response in the lungs.
    Fagan PK; Walker MJ; Chin J; Eamens GJ; Djordjevic SP
    Microb Pathog; 2001 Feb; 30(2):101-10. PubMed ID: 11162190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Occurrence of Mycoplasma hyopneumoniae infections in suckling and nursery pigs in a region of high pig density.
    Nathues H; Kubiak R; Tegeler R; grosse Beilage E
    Vet Rec; 2010 Feb; 166(7):194-8. PubMed ID: 20154309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.